BioNTech SE

BioNTech SE is a German biotechnology company that focuses on developing innovative therapies, particularly in cancer treatment and infectious diseases. It gained global recognition for creating one of the first COVID-19 vaccines, in collaboration with Pfizer, using messenger RNA (mRNA) technology. This approach teaches the body to recognize and fight viruses. Founded in 2008, BioNTech aims to harness the immune system to develop personalized treatments that specifically target tumors. Its advancements in mRNA technology hold promise for future vaccines and therapies, making it a key player in modern medical research and development.